Bioscreen | Growth Curves USA

References: ANTIMICROBIAL (ANTIBIOTIC BIOASSAYS, EFFECT OF CHEMICALS)
Bisignano , Filocamo A, Ginestra G, Giofre SV, Navarra M, Romeo R, Mandalari G., 3,4-DHPEA-EA from Olea Europaea L. is effective against standard and clinical isolates of Staphylococcus sp. *3,4-DHPEA-EA from Olea Europaea L. is effective against standard and clinical isolates of Staphylococcus sp., Ann Clin Microbiol Antimicrob. 2014 Jul 1;13(1):24. [Epub ahead of print] Okafor F, Janen A, Kukhtareva T, Edwards V, Curley M. Green synthesis of silver nanoparticles, their characterization, application and antibacterial activity.* Int J Environ Res Public Health. 2013 Oct 21;10(10):5221-38. doi: 10.3390/ijerph10105221. Callewaert, L., Aertsen, A., Deckers, D., Vanoirbeek, K.G.A., Vanderkelen, L., Van Herreweghe, J.M., Masschalck, B., Nakimbugwe, D., Robben, J. and C.W. Michiels. 2008. A new family of lysozyme inhibitors contributing to lysozyme tolerance in gram-negative bacteria. PLoS Pathogens 4(3): e1000019. doi:10.1371/journal.ppat.1000019 Cheeseman, K.E., Denyer, S.P., Hosein, I.K., Williams, G.J., and J.-Y. Maillard. 2009. Evaluation of the bactericidal efficacy of three different alcohol hand rubs against 57 clinical isolates of S. aureus. Journal of Hospital Infection 72: 319-325. Cooper, C.J., Denyer, S.P., and J.-Y. Maillard. 2011. Rapid and quantitative automated measurement of bacteriophage activity against cystic fibrosis isolates of Pseudomonas aeruginosa. Journal of Applied Microbiology 110: Simoes, J.A., Aroutcheva, A.A., Heimler, I., and S. Faro. 2004. *Antimicrobial resistance patterns of group B streptococcal clinical isolates.* Infect. Dis. Obstet. Gynecol. 12: 1-8. Danisco, Inc. Frequently Asked Questions: Anhydrofructose (AHF). 06 September 2009. DeVito, J.A., Mills, J.A., Liu, V.G., Agarwal, A., Sizemore, C.F., Yao, Z., Stoughton, D.M., Cappielo, M.G., Barbosa, M.D.F.S., Foster, L.A., and D.L. Pompliano. 2002. An array of target-specific screening strains for antibacterial discovery. Nature Biotechnology 20: 478-483. Fiskesund, R., Thomas, L.V., Schobert, M., Ernberg, I., Lundt, I. and S. Yu. 2009. Inhibition spectrum studies of microthecin and other anhydrofructose derivatives using selected strains of Gram-positive and Ðnegative bacteria, yeasts and moulds, and investigation of the cytotoxicity of microthecin to malignant blood cell lines. Journal of Applied Microbiology 106: 624-633. Hsu, K.L., Pilobello, K.T., and L.K. Mahal. 2006. Analyzing the dynamic bacterial glycome with a lectin microarray approach. Natural Chemical Biology 2: 1537-157. Sõderling, E.M., Ekman, T., and T.J. Taipale. 2008. Growth inhibition of Streptococcus mutans with low xylitol concentrations. Current Microbiology 56: 382-385. Thomas, L.V., Yu, S., Ingram, R.E., Refdahl, C., Elsser, D., and J. Delves-Broughton. 2002. *Ascopyrone P, a novel antibacterial derived from fungi.* Journal of Applied Microbiology 93: 679-705. Alakomi H-L, Paananen A, Suihko M-L, et. al., *Weakening effect of cell permeabilizers on gram-negative bacteria causing biodeterioration.* Applied and Environmental Microbiology 72:(2006) 4695-4703. (CN00469) Bacon CW, Hinton DM, Hinton A Jr., *Growth-inhibiting effects of concentrations of fusaric acid on the growth of Bacillus mojavensis and other biocontrol Bacillus species,* Journal of Applied Microbiology 100:(2006) 185-194. (CN00232) Métris A, George SM, Baranyi. J, *Use of optical density detection times to assess the effect of acetic acid on single-cell kinetics,* Applied and Environmental Microbiology 72:(2006) 6674-6679. (CN00457) Si W, Gong J, Tsao R, Zhou T, Yu H, Poppe C, Johsnon R, Du Z, *Antimicrobial activity of essential oils and structurally related synthetic food additives towards selected pathogenic and beneficial gut bacteria,* Journal of Applied Microbiology 100: (2006) 296-305. (CN00054) Allen J, Davey HM, Broadhurst D, et. al., *Discrimination of Modes of Action of Antifungal Substances by Use of Metabolic Footprinting,* Applied and Environmental Microbiology, October 2004, p. 6157-6165, Vol. 70, No. 10. (CN00151) Augustin M, Ali-Vehmas T, Faik Atroshi F, *Assessment of enzymatic cleaning agents and disinfectants against bacterial biofilms,* J. Pharm. Pharmaceutical Sci 7(1):55-64, 2004., www.ualberta.ca/~csps . (CN00075) Kim YS, Shin DH, *Volatile Constituents from the Leaves of Callicarpa japonica Thunb. and Their Antibacterial Activities,* J Agric Food Chem. 2004 Feb 25;52(4):781-787. (CN00467) Kugelberg E, Löfmark S, Wretlind B, Andersson DI, *Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa,* JAC Advance Access published online on December 1, 2004 Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh505. (CN00356) Lambert RJ, Hanlon GW, Denyer SP, *The synergistic effect of EDTA/antimicrobial combinations on Pseudomonas aeruginosa,* J Appl Microbiol. 2004; 96(2):244-253. (CN00437) Macvanin M, Ballagi A, Hughes D, *Fusidic Acid-Resistant Mutants of Salmonella enterica Serovar Typhimurium Have Low Levels of Heme and a Reduced Rate of Respiration and Are Sensitive to Oxidative Stress,* Antimicrobial Agents and Chemotherapy, October 2004, p. 3877-3883, Vol. 48, No. 10. (CN00208) Simoes JA, Aroutcheva AA, Heimler I, Faro S, *Antibiotic resistance patterns of group B streptococcal clinical isolates,* Infectious Diseases in Obstetrics and Gynecology 12: (2004) 1-8. (CN00052) Löwdin E, Odenholt I, Cars O, *In vitro studies of the pharmacodynamics of teicoplanin against Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium,* Clinical Microbiology & Infection, Volume 9, Issue 9, Page 930-937, September 2003. (CN00257) Macvanin M, Björkman J, Eriksson S, et. al., *Fusidic Acid-Resistant Mutants of Salmonella enterica Serovar Typhimurium with Low Fitness In Vivo Are Defective in RpoS Induction,* Antimicrobial Agents and Chemotherapy, December 2003, p. 3743-3749, Vol. 47, No. 12. (CN00209) Molin M, Norbeck A, Blomberg A, *Dihydroxyacetone kinases in Saccharomyces cerevisiae are involved in detoxification of dihydroxyacetone,* J. Biol. Chem., Vol. 278, Issue 3, 1415-1423, January 17, 2003 . (CN00150) Nilsson AI, Berg OG, Aspevall O, et. al., *Biological Costs and Mechanisms of Fosfomycin Resistance in Escherichia coli,* Antimicrobial Agents and Chemotherapy, September 2003, p. 2850-2858, Vol. 47, No. 9. (CN00097) Olasupo NA, Fitzgerald DJ, Gasson MJ, Narbad A, *Activity of natural antimicrobial compounds against Escherichia coli and Salmonella enterica serovar Typhimurium,* Lett Appl Microbiol. 2003;37(6):448-451. (CN00037) Kim KW, Thomas RL, Lee C, Hwang KT, Chen XG, Park HJ, Kim YT, *Antimicrobial activitivity of native, degraded chitosan and carboxymethylated chitosan,* IFT - Institute of Food Technologists, 2002 Annual Meeting - Anaheim, California, Session 29, Carbohydrate, 2:30 PM - 4:35 PM, Sunday, June 16. (CN00053) Mejlholm O, Dalgaard P, *Antimicrobial effect of essential oils on the seafood spoilage micro-organism Photobacterium phosphoreum in liquid media and fish products,* Letters in Applied Microbiology, 2002, 34 (1), pp. 27-31. (CN00062) Thomas LV, Yu S, Ingram RE, Refdahl CD, Elsser D, Delves-Broughton J, *Ascopyrone P, a novel antibacterial derived from fungi,* J. Appl. Microbiol., 2002, 93: pp. 697-705. (CN00072) Aroutcheva A, Simoes JA, Shott S, Faro S, *The inhibitory effect of clindamycin on Lactobacillus in vitro,* Infectious Diseases in Obstetrics and Gynecology 9: (2001) 231-244. (CN00422) Dominguez MC, de la Rosa M, Borobio MV, *Application of a spectrophotometric method for the determination of post-antibiotic effect and comparison with viable counts in agar,* Journal of Antimicrobial Chemotherapy (2001) 47, 391-398. (CN00067) Hujakka H, Ratilainen J, Korjamo T, et. al., *Synthesis and antimicrobial activity of the symmetric dimeric form of temporin A based on 3-N,N-di(3-aminopropyl)amino propanoic acid as the branching unit,* Bioorganic & Medicinal Chemistry, Volume 9, Issue 6, June 2001, Pages 1601-1607. (CN00401) Lambert RJW, Skandamis PN, Coote PJ, Nychas, GJE, *A study of the minimum inhibitory concentration and mode ofaction of oregano essential oil, thymol and carvacrol,* Journal of Applied Microbiology, Volume 91, Issue 3, Page 453-462, Sep 2001. (CN00029) Lambert RJ, *Susceptibility testing inoculum size dependency of inhibition using the Colworth MIC technique,* Journal of Applied Microbiology, 2000, Aug, 89(2), 275-279. (CN00398) Lambert RJ, Pearson J, *Susceptibility testing accurate and reproducible minimum inhibitory concentration (MIC) and non-inhibitory concentration (NIC) values,* Journal of Applied Microbiology, 2000, May, 88(5), 784-790. (CN00397) Niku-Paavola ML, Laitila A, Mattila-Sandholm T, Haikara A,, *New types of antimicrobial compounds produced by Lactobacillus plantarum,* Journal of Applied Microbiology, 1999, Jan, 86(1), 29-35. (CN00310) Ali-Vehmas T, Rizzo A., Westermarck T, Atroshi F, *Measurement of Antibacterial Activities of T-2 Toxin, Deoxynivalenol, Ochratoxin A, Aflatoxin B1 and Fumonisin B1 Using Microtitration Tray-based Turbidimetric Techiques,* Journal of Veterinary Medicine, 1998, vol. A 45, pp. 453-458. (CN00281) Coote PJ, Holyoak CD, Bracey D, Ferdinando DP, Pearce JA, *Inhibitory Action of a Truncated Derivative of the Amphibian Skin Peptide Dermaseptin s3 on Saccharomyces cerevisiae,* Antimicrobial Agents and Chemotherapy, September 1998, p. 2160-2170, Vol. 42, No. 9. (CN00269) Löwdin E, Odenholt I, Cars O, *In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidis,* Antimicrobial Agents and Chemotherapy 1998 Oct, vol. 42, (10), pp. 2739-2744. (CN00256) Odenholt I, Löwdin E, Cars O, *In Vitro Pharmacodynamic Studies of L-749,345 in Comparison with Imipenem and Ceftriaxone against Gram-Positive and Gram-Negative Bacteria,* Antimicrobial Agents and Chemotherapy, September 1998, p. 2365-2370, Vol. 42, No. 9. (CN00255) Johansson A, Sunzel, B, Holm SE, Soderberg T, Gref R, *Antimicrobial screening of zinc in the absence or presence of oleoresins and various resin acids* APMIS, 1995, vol. 103, (6), pp. 419-427. (CN00063) Cavedoni L., Pastoni F, Brema C, Maestri L, Vignola C, *[Application of the spectrophotometric method to determine the bactericidal efficacy of the new synthesized molecules]* (Ital.), abstr., XXIII National Congress of Italian Clinical Microbiology Association, 1994, 1 pp. (CN00477) Pastoni F, Marengo G, Cavedoni L, Vignola L, Maestri L, *[Application of kinetical studies on micro-organisms to test its efficacy on new antibacterial agents],* (Ital.), abstr., XXIII National Congress of Italian Clinical Microbiology Association, 1994, 1 pp. (CN00475) Skyttä E, Haikara A, Mattila-Sandholm T, *Production and characterization of antibacterial compounds produced by Pediococcus damnosus and Pediococcus Pentosaceus,* J. of Applied Bacteriology, 1993, vol. 74, (2), pp. 134-142. (CN00343) Olsson-Liljequist B, Hoffman BM,, *In-vitro activity of clarithromycin combined with its 14-hydroxy metabolite A- 62671 against Haemophilus influenzae,* Journal of Antimicrobial Chemotheraphy, 1991, vol. 27, Suppl. A, pp. 11-17. (CN00258) Skyttä E, Mattila-Sandholm T, *A quantitative method for assessing bacteriocins and other food antimicrobials by automated turbidometry,* Journal of Microbiological Methods, 1991, vol. 14, pp. 77-88. (CN00024) Adams MR, Hall C, *Growth inhibition of food-borne pathogens by lactic and acetic acid and their mixtures* International Journal of Food Science and Technology, 1988, vol. 23, (3), pp. 287-292. (CN00221) Korkeala H, Männistö PT, *Time course of the antibacterial activity of erythromycin stearate and erythromycin acistrate against two Staphylococcus aureus strains in vitro,* Journal of Antimicrobial Chemotherapy, 1988, vol. 22, pp. 127-133. (CN00442) Labsystems Corp., Research Laboratories,, Automated antimicrobial testing by Bioscreen on a quantitative basis, microbiological assay of erythromycin, chloramphenicol, demeclocycline, neomycin sulfate, oxytetracycline, rifamycin and tetracycline, Labsystems, Finland, 1988, 42 pp. (CN00076) Butcher S, *The Growth of Contaminating Lactobacilli and Production Organisms under Inhibitory Conditions* Report of Finnish Government Alcoholic Industry Research Laboratories, A-13074, 6.10.1987, pp. 42 +2. (CN00419) Löwdin E, Odenholt-Tornqvist I, Bengtsson S, Cars O, *A new method to determine postantibiotic effect and effect of subinhibitory antibiotic concentrations,* Antimicrobial Agents and Chemotherapy, 1993, vol. 37, (10), pp. 2200-2205. (CN00019)

©2020 Growth Curves USA